DEA bans “Pink”

Posted in Blog | 0 comments

DEA bans “Pink” This week, the US Drug enforcement Administration (DEA) classified “Pink” a schedule I drug. The synthetic opioid has caused at least 46 confirmed deaths and has been proven to have a high potential for abuse with no approved medical use. Thirty-one of those deaths occurred in New York and 10 in North Carolina but Pink has also been seen elsewhere. Law enforcement has seen Pink in both powder and tablet form. The tablets appear to have been made to mimic prescription opioids, putting users...

Read More